| 1 |
34939081 | Development of an exoglycosidase plate-based assay for detecting α1-3,4 fucosylation biomarker in individuals with HNF1A-MODY. | 2022 Mar 30 |
1 |
| 2 |
33765222 | Interlaboratory evaluation of plasma N-glycan antennary fucosylation as a clinical biomarker for HNF1A-MODY using liquid chromatography methods. | 2021 Jun |
2 |
| 3 |
30455330 | Plasma Fucosylated Glycans and C-Reactive Protein as Biomarkers of HNF1A-MODY in Young Adult-Onset Nonautoimmune Diabetes. | 2019 Jan |
1 |
| 4 |
31410472 | Antagonistic and synergistic epigenetic modulation using orthologous CRISPR/dCas9-based modular system. | 2019 Oct 10 |
1 |
| 5 |
23274891 | Mutations in HNF1A result in marked alterations of plasma glycan profile. | 2013 Apr |
5 |
| 6 |
23760703 | Monogenic diabetes: old and new approaches to diagnosis. | 2013 Jun |
1 |
| 7 |
22395466 | Epigenetic silencing of HNF1A associates with changes in the composition of the human plasma N-glycome. | 2012 Feb |
6 |
| 8 |
23539835 | Maturity onset diabetes of the young: clinical characteristics, diagnosis and management. | 2012 Dec-2013 Jan |
1 |
| 9 |
21908519 | Polymorphisms in B3GAT1, SLC9A9 and MGAT5 are associated with variation within the human plasma N-glycome of 3533 European adults. | 2011 Dec 15 |
1 |